Cargando…
Tinzaparin Sodium Pharmacokinetics in Patients with Chronic Kidney Disease: Practical Implications
Low-molecular-weight heparins (LMWHs) are the mainstay of the prophylaxis and treatment of venous thromboembolism (VTE). Due to their renal elimination, the risk of accumulation with the related bleeding risk may represent a limitation for the use of LMWHs in patients with chronic kidney disease (CK...
Autores principales: | Helfer, Hélène, Siguret, Virginie, Mahé, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266849/ https://www.ncbi.nlm.nih.gov/pubmed/31721053 http://dx.doi.org/10.1007/s40256-019-00382-0 |
Ejemplares similares
-
Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties
por: Smit, Cornelis, et al.
Publicado: (2020) -
Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
por: Turakhia, Mintu P, et al.
Publicado: (2018) -
Pharmacokinetics and Generic Drug Switching: A Regulator’s View
por: Glerum, Pieter J., et al.
Publicado: (2020) -
Combining Isotopic Tracer Techniques to Increase Efficiency of Clinical Pharmacokinetic Trials in Oncology
por: Roosendaal, Jeroen, et al.
Publicado: (2020) -
Heparin/tinzaparin-sodium: Lack of efficacy: 3 case reports
Publicado: (2020)